论文部分内容阅读
单克隆抗体 B72.3已用作肿瘤显影剂检查,其肿瘤相关性糖蛋白靶物(TAG-72)可与94%结肠腺癌起反应,B72.3的免疫接合物已供结直肠癌临床研究之用,作者采取~(111)In-CYT-103(B72.3的免疫结合物)进行观察。
Monoclonal antibody B72.3 has been used as a tumor imaging agent. Its tumor-associated glycoprotein target (TAG-72) can react with 94% of colon adenocarcinomas. B72.3 immunoconjugate has been used for colorectal cancer. For the purpose of the study, the authors adopted ~(111)In-CYT-103 (immunoconjugate of B72.3) for observation.